MS
Matthew Shair (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Nuvalent Inc (NUVL). The largest single filing was $600K of NUVL (5,481 sh across 3 lots, as filed), executed Nov 24 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 24 2025
Filed Nov 26 2025
Median ADV $288.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
NUVLRecent filings
NUVLSALE
Nuvalent Inc
View filing →
$600K5,481 sh across 3 lots
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $6.0M
60,000 sh across 4 lots
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $108K
1,382 sh × $78.49
Exec Feb 24 2025
Filed Feb 25 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $118K
1,409 sh × $83.62
Exec Dec 23 2024
Filed Dec 26 2024 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $108K
1,181 sh × $91.31
Exec Oct 28 2024
Filed Oct 30 2024 · 5:30 PM ET